The Hidden Trap in AI’s Hottest Stocks: Why ‘Boring’ Is Now Winning
The numbers coming out of Big Tech’s July earnings season look impressive — revenue beats, AI hype at full throttle, and market caps measuring in the trillions. But step back, and a quieter and more instructive story is unfolding in the data. The Magnificent Seven stocks are collectively trading at roughly 11 times sales and 70 times earnings. At the peak of the dot-com bubble in March 2000, the era’s five dominant technology giants — Microsoft, Cisco, Intel, Oracle, and IBM — traded at 11 times sales and 54 times earnings. That comparison is worth sitting with. Today’s AI leaders are more expensively priced than the companies that preceded one of the most brutal 20-year stretches in market history. Investors who bought those dot-com giants at the peak and held through the bust waited until 2020 — a full two decades — to merely break even.
The parallel isn’t meant to predict a crash. Markets can stay irrational longer than most people expect, and the underlying technology this time is genuine. The lesson isn’t “sell everything” — it’s about price. As InvestorPlace analyst Eric Fry pointed out this week, the dot-com leaders were right about the future; they were catastrophically wrong about the valuations investors assigned to that future. The same dynamic may be playing out today. Meta has now guided for $125 billion to $145 billion in capital expenditures for 2026, up from its prior range of $115 billion to $135 billion. Amazon, Alphabet, and Microsoft are spending similarly staggering sums, with an AI researcher at NYU calling it the “greatest capital misallocation in history” — spending at a rate of more than 12 times the Manhattan Project every single year. Meanwhile, the Philadelphia Semiconductor Index (SOX) is down more than 22% in July alone, its sixth-worst month on record, as questions about circular financing and AI demand sustainability catch up with the most crowded trade on Wall Street.
The rotation that follows boom peaks has a reliable historical pattern: the leaders of the previous cycle rarely lead the next one. In the years after the 2000 tech peak, the compounding came from energy, materials, financials, healthcare, and consumer staples — the “boring” sectors that had been starved of capital while everyone chased bandwidth stocks. Today, patient investors might find the same dynamic emerging. Healthcare stocks and financials have quietly outperformed tech in recent weeks, with Morgan Stanley upgrading quality-dividend names in both sectors. The S&P 500’s tech weighting sits near all-time highs even as earnings growth in non-tech sectors begins to accelerate. For long-term investors, the question isn’t whether to abandon growth entirely — it’s whether the valuations being paid for that growth leave any margin of safety. At 70 times earnings, the Mag 7 as a group prices in perfection. History suggests that, for patient capital, the better compounding opportunities are often found precisely where no one is looking: in the “boring” companies with reasonable valuations, durable cash flows, and the advantage of being invisible to the excitement-chasing crowd.
